Corcept Therapeutics Inc. (CORT) is a publicly traded Healthcare sector company. As of July 18, 2026, CORT trades at $90.55 with a market cap of $9.63B and a P/E ratio of 89.78. CORT moved +0.84% today. Year to date, CORT is +160.12%; over the trailing twelve months it is +23.83%. Its 52-week range spans $28.66 to $117.33. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces CORT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CORT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $90.55 |
| Market Cap | $9.63B |
| P/E Ratio | 89.78 |
| EPS | $1.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $117.33 |
| 52-Week Low | $28.66 |
| Volume | 855.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $741.17M |
| Net Income | $106.11M |
| Gross Margin | 98.19% |
4 analysts cover CORT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.